Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
LY3200882
Cat. No.:
OB0225LY-0210
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR and HPLC.
Size:
Product Overview
Description:
LY3200882 is a small molecule research compound designed to modulate specific biological pathways.
Synonym:
1898283-02-7; LY3200882; 2-(4-((4-((1-Cyclopropyl-3-(tetrahydro-2H-pyran-4-yl)-1H-pyrazol-4-yl)oxy)pyridin-2-yl)amino)pyridin-2-yl)propan-2-ol; 2-[4-[[4-[1-Cyclopropyl-3-(oxan-4-yl)pyrazol-4-yl]oxypyridin-2-yl]amino]pyridin-2-yl]propan-2-ol; 2-(4-(4-(1-Cyclopropyl-3-(tetrahydro-2H-pyran-4-yl)-1H-pyrazol-4-yloxy)pyridin-2-ylamino)pyridin-2-yl)propan-2-ol
CAS No.:
1898283-02-7
Compound CID:
121249291
Formula:
C24H29N5O3
Formula Weight:
435.52
Specification
Relative Density:
1.36 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
LY3200882 can be used in metabolic regulation studies or play an important role in developing novel drug screening.
Library Information
Targets:
TGF-β receptor family
Receptors:
TGF-βRI (ALK5)
Pathways:
Stem cells
Plate Number:
AOCL-3
Plate Location:
f4
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
4.36 mg/mL; 10 mM
ALogP:
3.363
HBA_Count:
5
HBD_Count:
1
Rotatable Bond:
7
